Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Zhang, Weili ^a   Chen, Yu ^a   Yang, Xiaomin ^b   Fan, Jingyao ^a   Mi, Xuenan ^a   Wang, Jizheng ^a   Zhang, Channa ^a   Hu, Frank B ^c   Hui, Rutai ^a  

^a FUWAI HOSPITAL   (China)

^b BAOTOU MEDICAL COLLEGE   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CYTOSINE; THYMINE;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; CHINA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIGH RISK POPULATION; HTERT GENE; HUMAN; HUMAN CELL; HYPERTENSION; IN VIVO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PROMOTER REGION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; RURAL POPULATION; TELOMERE SHORTENING;

FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TELOMERASE; TELOMERE SHORTENING; TRANSCRIPTION, GENETIC;

EID: 84867628335     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047029     Document Type: Article

References (47)

1. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, et al. (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326: 381-386.
2. Zheng ZJ, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, et al. (1997) Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 131: 115-125.
3. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, et al. (1999) Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19: 538-545.
4. Hooi JD, Kester AD, Stoffers HE, Rinkens PE, Knottnerus JA, et al. (2004) Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol 57: 294-300.
5. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, et al. (2003) Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163: 884-892.
6. Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M, (2004) Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis 175: 131-138.
7. Hayoz D, Bounameaux H, Canova CR, (2005) Swiss Atherothrombosis Survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease. J Intern Med 258: 238-243.
8. Hasimu B, Li J, Nakayama T, Yu J, Yang J, et al. (2006) Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk. Hypertens Res 29: 23-28.
9. Yang X, Sun K, Zhang W, Wu H, Zhang H, et al. (2007) Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese. J Vasc Surg 46: 296-302.
10. Blackburn EH, (1991) Structure and function of telomeres. Nature 350: 569-573.
11. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, et al. (2002) Endothelial cell senescence in human atherosclerosis: Role of telomere in endothelial dysfunction. Circulation 105: 1541-1544.
12. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, et al. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
13. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, et al. (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019.
14. Ducrest AL, Szutorisz H, Lingner J, Nabholz M, (2002) Regulation of the human telomerase reverse transcriptase gene. Oncogene 21: 541-552.
15. Yang J, Chang E, Cherry AM, Bangs CD, Oei Y, et al. (1999) Human endothelial cell life extension by telomerase expression. J Biol Chem 274: 26141-26148.
16. O'Hare MJ, Bond J, Clarke C, Takeuchi Y, Atherton AJ, et al. (2001) Conditional immortalization of freshly isolated human mammary fibroblasts and endothelial cells. Proc Natl Acad Sci U S A 98: 646-651.
17. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, et al. (1996) Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5: 685-691.
18. Bischoff C, Graakjaer J, Petersen HC, Hjelmborg JB, Vaupel JW, et al. (2005) The heritability of telomere length among the elderly and oldest-old. Twin Res Hum Genet 8: 433-439.
19. Vasa-Nicotera M, Brouilette S, Mangino M, Thompson JR, Braund P, et al. (2005) Mapping of a major locus that determines telomere length in humans. Am J Hum Genet 76: 147-151.
20. Andrew T, Aviv A, Falchi M, Surdulescu GL, Gardner JP, et al. (2006) Mapping genetic loci that determine leukocyte telomere length in a large sample of unselected female sibling pairs. Am J Hum Genet 2006 78: 480-486.
21. Mangino M, Brouilette S, Braund P, Tirmizi N, Vasa-Nicotera M, et al. (2008) A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet 17: 2518-2523.
22. Mangino M, Richards JB, Soranzo N, Zhai G, Aviv A, et al. (2009) A genome-wide association study identifies a novel locus on chromosome 18q12.2 influencing white cell telomere length. J Med Genet 46: 451-454.
23. Codd V, Mangino M, van der Harst P, Braund PS, Kaiser M, et al. (2010) Common variants near terc are associated with mean telomere length. Nat Genet 42: 197-199.
24. Prescott J, Kraft P, Chasman DI, Savage SA, Mirabello L, et al. (2011) Genome-wide association study of relative telomere length. PLoS One 6: e19635.
25. Levy D, Neuhausen SL, Hunt SC, Kimura M, Hwang SJ, et al. (2010) Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology. Proc Natl Acad Sci USA 107: 9293-9238.
26. Gu J, Chen M, Shete S, Amos CI, Kamat A, et al. (2011) A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prev Res 4: 514-521.
27. Zee RY, Ridker PM, Chasman DI, (2011) Genetic variants in eleven telomere-associated genes and the risk of incident cardio/cerebrovascular disease: The Women's Genome Health Study. Clin Chim Acta 412: 199-202.
28. Matsubara Y, Murata M, Watanabe K, Saito I, Miyaki K, et al. (2006) Coronary artery disease and a functional polymorphism of hTERT. Biochem Biophys Res Commun 348: 669-672.
29. Nordfjall K, Osterman P, Melander O, Nilsson P, Roos G, (2007) hTERT (-1327)T/C polymorphism is not associated with age-related telomere attrition in peripheral blood. Biochem Biophys Res Commun 358: 215-218.
30. Soerensen M, Thinggaard M, Nygaard M, Dato S, Tan Q, et al. (2012) Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and longitudinal analysis. Aging Cell 11: 223-227.
31. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall AH, (2001) Telomere shortening in atherosclerosis. Lancet 358: 472-473.
32. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, et al. (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested casecontrol study. Lancet 369: 107-114.
33. Knowles JW, Assimes TL, Li J, Quertermous T, Cooke JP, (2007) Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol 27: 2068-2078.
34. McDermott MM, Lloyd-Jones DM, (2009) The role of biomarkers and genetics in peripheral arterial disease. J Am Coll Cardiol 54: 1228-1237.
35. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, et al. (2000) Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 101: E16-22.
36. Cawthon RM, (2002) Telomere measurement by quantitative PCR. Nucleic Acids Res 30: e47.
37. Horikawa I, Cable PL, Afshari C, Barrett JC, (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59: 826-830.
38. Hsu CP, Hsu NY, Lee LW, Ko JL, (2006) Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter: effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. Eur J Cancer 42: 1466e74.
39. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, et al. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557.
40. Simes RJ, (1986) An improved Bonferroni procedure for multiple tests of significance. Biometrika 73: 751-754.
41. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL, (2004) A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68: 165-177.
42. Gauderman WJ, Morrison JM (2006) Quanto 1.1: a computer program for power and sample size calculations for genetic epidemiology studies (http://hydra.usc.edu/gxe).
43. Ju Z, Jiang H, Jaworski M, Rathinam C, Gompf A, et al. (2007) Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment. Nat Med 13: 742-747.
44. Calado RT, Young NS, (2009) Telomere diseases. N Engl J Med 361: 2353-2365.
45. Blackburn EH, Greider CW, Szostak JW, (2006) Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12: 1133-1138.
46. Fehrer C, Voglauer R, Wieser M, Pfister G, Brunauer R, et al. (2006) Techniques in gerontology: Cell lines as standards for telomere length and telomerase activity assessment. Exp Gerontol 41: 648-651.
47. Shen Q, Zhang Z, Yu L, Cao L, Zhou D, et al. (2011) Common variants near TERC are associated with leukocyte telomere length in the Chinese Han population. Eur J Hum Genet 19: 721-723.